Contact
Print
Urology & Nephrology
PSI is a leading full-service CRO with 800+ staff in Europe (Eastern, Central, Western), the USA and Latin America.
PSI is known and respected for consistently securing fast patient enrollment into clinical trials of all sizes and levels of complexity, across a broad range of indications.
PSI has successfully performed Phase II/III studies in the following urology and nephrology indications:
PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including internists, medical oncologists, gynecologists, urologists, and dialysis specialists.
PSI is known and respected for consistently securing fast patient enrollment into clinical trials of all sizes and levels of complexity, across a broad range of indications.
PSI has successfully performed Phase II/III studies in the following urology and nephrology indications:
- Benign prostatic hyperplasia
- Bladder malignancies
- Chronic prostatitis
- Diabetic nephropathy
- Prostate cancer
- Pyelonephritis
- Renal anemia
- Renal carcinoma
- Renal insufficiency/failure
- Urinary incontinence/Overactive bladder
- UTI (cystitis, urethritis)
| Urology / Nephrology Indications | # Sites |
| Benign prostatic hyperplasia | 131 |
| Bladder malignancies | 79 |
| Chronic prostatitis | 139 |
| Diabetic nephropathy | 31 |
| Prostate cancer | 119 |
| Pyelonephritis | 118 |
| Renal carcinoma | 83 |
| Renal insufficiency/failure | 78 |
| Urinary incontinence/Overactive bladder | 97 |
| UTI | 139 |
| 1,014 |